Company: CNTB
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001835268-25-000014
Chunk: 29

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-03-31
Form: 10-K
Item: Item 12
Chunk 29
---
 with Lily Asia Ventures (“LAV”) (7)3,336,9076.0%Named Executive Officers and Directors:Barry D. Quart, Pharm.D. (8)131,887*Kleanthis G. Xanthopoulos, Ph.D. (9)252,388*Kan Chen, Ph.D. (10)— —James Z. Huang (1)13,760,000 24.9%Jean Liu, J.D. (11)102,988*Karen J. Wilson, CPA (12)168,208*David Szekeres (13)160,867*Lisa Peraza, CPA— —Zheng Wei, Ph.D. (2)6,683,690 11.9%Wubin Pan, Ph.D. (3) (14)6,982,267 12.4%Steven Chan (15)284,791 *All current executive officers and directors as a group (16)14,576,338 26.1%

*Indicates beneficial ownership of less than 1% of the total outstanding ordinary shares.

**Includes ordinary shares represented by ADSs.

(1) Panacea Venture Healthcare Fund II, L.P. stated that it holds 13,760,000 ordinary shares. James Huang is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. James Huang, a member of our Board, is the sole owner of Panacea Innovation Limited, which is the sole owner of Panacea Venture Healthcare Fund II GP Company, Ltd., which is the general partner of Panacea Venture Healthcare Fund II, L.P. As a result, each of James Huang, Panacea Innovation Limited and Panacea Venture Healthcare Fund II GP Company, Ltd. may be deemed to share beneficial ownership of the Ordinary Shares directly reported herein, but each disclaims such beneficial 

150

TABLE OF CONTENTS

ownership. The registered address of the Panacea entities is c/o Maples Corporate Services Limited, Ugland House, Grand Cayman KY1-1104, Cayman Islands.

(2) As reported on a Schedule 13G/A filed February 13, 2024, Dr. Zheng holds 5,928,164 ordinary shares. In addition, as of March 21, 2025, Dr. Zheng beneficially owns 755,526 ordinary shares underlying options that are